华贻军 - 中山大学 - 肿瘤防治中心

个人简介

教育经历:　2010/09-2013/06 中山大学，肿瘤学博士　2003/09-2006/06 中山大学，临床肿瘤学硕士，硕士　1998/09-2003/06 华中科技大学同济医学院（同济医科大学），临床医学学士科研与学术工作经历：　2019/01 - 　　中山大学, 肿瘤防治中心，副主任医师　2017/09 - 2017/11 澳大利亚Monash医学中心，参观学习　2013/09 - 2014/09 澳大利亚西悉尼大学，Ingham Institute，访问学者　2011/01 - 2018/12 中山大学, 肿瘤防治中心，主治医师　2006/08 - 2010/12 中山大学，肿瘤防治中心，住院医师

研究领域

擅长于鼻咽癌的放射治疗、化学治疗和靶向治疗的综合治疗

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.You R#, Hua YJ#, Liu YP, et al. Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up. Theranostics. 2017 Jun 1;7(8):2314-2324. doi: 10.7150/thno.19710. eCollection 2017.2.You R#, Sun R#, Hua YJ#, Li CF, Li JB, Zou X, Yang Q, Liu YP, Zhang YN, Yu T, Cao JY, Zhang MX, Jiang R, Mo HY, Guo L, Cao KJ, Lin AH, Qian CN, Sun Y, Ma J, Chen MY. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma. Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30819. [Epub ahead of print] 3.Hua YJ#, Wang HY#, Tang LQ, Chen QY, Shao JY*, Mai HQ*. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.Oncotarget. 2016 Jan 23. doi: 10.18632/oncotarget.6996. [Epub ahead of print]4.Hua YJ, Wang HY, Tang LQ, Chen QY, Shao JY, Mai HQ. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome. Oncotarget. 2016 Jan 23. doi: 10.18632/oncotarget.6996. [Epub ahead of print]5.Zhang MX, Hua YJ, Wang HY, Zhou L, Mai HQ, Guo X, Zhao C, Huang WL, Hong MH, Chen MY. Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma. Oncotarget. 2016 Feb 1. doi: 10.18632/oncotarget.7116. [Epub ahead of print]6.Hu JL, Hua YJ, Chen Y, Yu B, Gao S. Structural analysis of tumor-related single amino acid mutations in human MxA protein. Chin J Cancer. 2015 Sep 28;34(3):55.7.Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX, Zhao C*. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy, Eur J Cancer. 2012，48(18): 3422-8 (in English)8.You R, Zou X, Hua YJ, Han F, Li L, Zhao C, Hong MH, Chen MY. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison. Radiother Oncol. 2015 Jun;115(3):399-406.9.Chen MY, Mai HQ, Sun R, Guo X, Zhao C, Hong MH, Hua YJ. Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Chin J Cancer. 2013，32(10): 533-810.Fu X, Hu J, Han HY, Hua YJ, Zhou L, Shuai WD, Du WY, Kuang CM, Chen S, Huang W, Liu RY. High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy. Oncotarget. 2015 Sep 29;6(29):28478-9011.Liang YY, Chen MY, Hua YJ, Chen S, Zheng LS, Cao X, Peng LX, Xie P, Huang BJ, Sun R, Wang L, Xiang YQ, Guo X, Qian CN.Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells. PLoS One. 2014 Jul 16;9(7)12.Lin HX, Hua YJ, Chen QY, Luo DH, Sun R, Qiu F, Mo HY, Mai HQ, Guo X, Xian LJ, Hong MH, Guo L.Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Chin J Cancer. 2013;32(9):502-11.13.Chen MY, Hua YJ, Wan XB, et al. A posteriorly pedicled middle turbinate mucoperiosteal flap resurfacing nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 2012 Mar; 146(3):409-11. Epub 2012 Jan 6. (In English)14.Yi-Jun Hua, Ming-Yuan Chen, Chao-Nan Qian, Ming-Huang Hong, Chong Zhao, Ling Guo, Xiang Guo,Kao-jia Cao. Postradiation Nasopharyngeal Necrosis in the Patients with Nasopharyngeal Carcinoma. Head & Neck. 2009,6(31): 807-812 (in English)15.Yi-Jun Hua, Shu Yu, Ming-Huang Hong，Xiao-Wei Yang, Fang Qiu, Ling Guo, Pei-Yu Huang,Guo-Yi Zhang. Application of Support Vector Machine to predict 5-Year Survival Status of Patients with Nasopharyngeal Carcinoma after Treatment. The Chinese-German journal of clinical oncology. 2006.5:8-12 (in English)16.Yi-Jun Hua, Ming Huang Hong, Chong Zhao, et al. Short-term Efficacy of Endoscopy-guided Debridement on Radiation-related Nasopharyngeal Necrosis in 20 Nasopharyngeal Carcinoma Patients after Radiotherapy. The Chinese Journal of Cancer, 2008，27（7）734-738 (in English)17.Hua YJ, Hong MH, Guo L, Chen QY, Xiang YQ, Huang PY. The Application of Artificial Neural Network to Prediction of 5-year Survival in Nasopharygeal Carcinoma. Journal of Oncoloy (Chinese) 2006; 12(4): 300-304. (in Chinese)18.Ming-Yuan Chen, MD, PhD; Wei-Ping Wen, MD, PhD; Xiang Guo, MD, PhD; An-Kui Yang, MD;Chao-Nan Qian, MD, PhD; Yi-Jun Hua, MD; Xiang-Bo Wan, MD; Zhu-Ming Guo, MD;Tian-Ying Li, MD; Ming-Huang Hong, MD. Endoscopic Nasopharyngectomy for Locally Recurrent Nasopharyngeal Carcinoma. The Laryngoscope. , 2009, 119(3):516-22 (in English)